Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr309.10 DKK
Change Today -6.90 / -2.18%
Volume 426.2K
As of 8:06 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by NOVOZYMES A/S-B SHARES (NZYMB) in the last 6 months

Announced 01/20/15
2.00B for Novozymes A/S
Buyback

Novozymes A/S (CPSE:NZYM B) announces a share repurchase program. Under the program, the company will repurchase up to 20,000,000 shares for DKK 2,000 million. The maximum number of shares to be purchased by the company per daily market session will be equivalent to no more than 25% of the average volume of shares in the company traded on NASDAQ OMX Copenhagen during the preceding 20 business days. The program will run in accordance with the provisions of European Commission ...
Read More


NZYMB's price was unchanged after the transaction was announced on 01/20/15.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr309.20 DKK -6.80

NZYMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chr Hansen Holding A/S kr324.20 DKK +1.00
Ebro Foods SA €16.97 EUR -0.01
EMS-Chemie Holding AG SFr.393.25 CHF -4.25
Kerry Group PLC €64.47 EUR -0.33
Sensient Technologies Corp $65.90 USD -0.55
View Industry Companies
 

Industry Analysis

NZYMB

Industry Average

Valuation NZYMB Industry Range
Price/Earnings 40.5x
Price/Sales 7.8x
Price/Book 9.0x
Price/Cash Flow 33.6x
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.